Cargando…
Clinical experience with triptans
Many drugs are now available for treating migraine attacks, including agents specifically indicated for this condition. Since 1990 sumatriptan, the first 5–HT(1B,1D) receptor agonist, was introduced and realized a real breakthrough in therapy; other agents of this class of drugs called triptans have...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3451834/ http://dx.doi.org/10.1007/s101940170021 |